Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
Pathological alterations to the locus coeruleus, the major source of noradrenaline in the
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …
The locus coeruleus: essential for maintaining cognitive function and the aging brain
Research on cognitive aging has focused on how decline in various cortical and
hippocampal regions influence cognition. However, brainstem regions play essential …
hippocampal regions influence cognition. However, brainstem regions play essential …
[HTML][HTML] The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer's disease: A narrative review
E Aaldijk, Y Vermeiren - Ageing Research Reviews, 2022 - Elsevier
Alzheimer's disease (AD) is the most common cause of dementia, accounting for more than
50 million patients worldwide. Current evidence suggests the exact mechanism behind this …
50 million patients worldwide. Current evidence suggests the exact mechanism behind this …
Long road to ruin: noradrenergic dysfunction in neurodegenerative disease
D Weinshenker - Trends in neurosciences, 2018 - cell.com
It has been known for decades that degeneration of the locus coeruleus (LC), the major
noradrenergic nucleus in the brain, occurs in both Alzheimer's disease (AD) and Parkinson's …
noradrenergic nucleus in the brain, occurs in both Alzheimer's disease (AD) and Parkinson's …
[HTML][HTML] Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease
SC Kelly, B He, SE Perez, SD Ginsberg… - Acta neuropathologica …, 2017 - Springer
A major feature of Alzheimer's disease (AD) is the loss of noradrenergic locus coeruleus
(LC) projection neurons that mediate attention, memory, and arousal. However, the extent to …
(LC) projection neurons that mediate attention, memory, and arousal. However, the extent to …
Monoaminergic neuropathology in Alzheimer's disease
None of the proposed mechanisms of Alzheimer's disease (AD) fully explains the distribution
patterns of the neuropathological changes at the cellular and regional levels, and their …
patterns of the neuropathological changes at the cellular and regional levels, and their …
Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care
Extensive neuropathological studies have established a compelling link between
abnormalities in structure and function of subcortical monoaminergic (MA-ergic) systems …
abnormalities in structure and function of subcortical monoaminergic (MA-ergic) systems …
Oxidative stress: free radical production in neural degeneration
ME Götz, G Künig, P Riederer, MBH Youdim - Pharmacology & therapeutics, 1994 - Elsevier
It is not yet established whether oxidative stress is a major cause of cell death or simply a
consequence of an unknown pathogenetic factor. Concerning chronic diseases, as …
consequence of an unknown pathogenetic factor. Concerning chronic diseases, as …
The neuropathology of aminergic nuclei in Alzheimer's disease
RM Zweig, CA Ross, JC Hedreen… - Annals of Neurology …, 1988 - Wiley Online Library
Neuronal loss and the presence of neurofibrillary tangles (NFTs) within aminergic nuclei
were examined in a series of patients with Alzheimer's disease (AD). Neuromelanin …
were examined in a series of patients with Alzheimer's disease (AD). Neuromelanin …
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
The locus coeruleus is the initial site of Alzheimer's disease neuropathology, with
hyperphosphorylated Tau appearing in early adulthood followed by neurodegeneration in …
hyperphosphorylated Tau appearing in early adulthood followed by neurodegeneration in …